Year
|
Date
|
Title of clinical trial
|
Source
|
| 2008 |
2008 |
Nventa unveils positive immunological data from HSPE7 phase 1 trial |
 |
2003-
2005 |
2003-
2005 |
Human Papillomavirus Infection and Cervical Cytology in Women Screened for Cervical Cancer in the United States, 2003–2005 |
 |
| 2001 - 2003 |
2001- 2003 |
Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: Study of JROSG (Japan Radiation Oncology Study Group)
|
informa healthcare |
| 2008 |
March |
Promising new Cervical Cancer Treatment |
 |
| 1999 to 2006 |
Dec 1999 to Sept 2006 |
This study was set up to determine the most appropriate way to deal with HPV positive results and associated psychological issues. The MRC funded Trial of Management of Borderline and other Low grade Abnormal smears (TOMBOLA), started recruitment of women in December 1999 and was a seven year multi-centre trial run from Dundee, Aberdeen and Nottingham.
|
 |
| 2000 to 2006 |
April 2000 to end of March 2006 |
A randomised trial of human papillomavirus (HPV) testing in primary cervical screening (ARTISTIC)
|
ISRCTN |
| 2001 |
May 2001 to November 2001 |
Evaluation of adjunctive HPV testing by Hybrid Capture II® in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy |
 |
| 2002 to 2007 |
Aug '02 to April '07 |
Healing touch and immunity in advanced cervical cancer patients |
Clinical Trials |
2003 to unknown date
|
April 2003 to unknown date
|
ICVT - phase II study |
Henderson Morley |
| 2003 to unknown date |
Feb '03 to unknown date |
Oxaliplatin and Paclitaxel in treating patients with locally recurrent or metastatic cervical cancer |
Clinical Trials |
| 2003 to 2007 |
Feb '03 to Jan '07 |
Chemotherapy and surgery or chemotherapy and radiotherapy for cervical cancer (EORTC 55994) |
CancerHelp UK |
| 2004 to unknown date |
June '04 to unknown date |
Irinotecan study for cervical cancer |
Clinical Trials |
| 2004 to unknown date |
July '04 to unknown date |
Lymph node mapping and sentinel lymph node identification in patients with stage IB1 cervical cancer |
Clinical Trials |
| 2004 to 2007 |
Sep '04 to Aug '07
|
Whether a dietary supplement can affect abnormal cervical cells (CRISP-1) |
CancerHelp UK |
| 2005 to 2007 |
June 2005 and still open |
Phase II study of neoadjuvant chemotherapy comprising dose-dense Paclitaxel and Carboplatin followed by Cisplatin and radiotherapy in patients with stage IB2-IVA cervical cancer |
 |
| 2005 to 2007 |
until July '08 |
MAVARIC - a controlled prospective comparison of automated and manual reading of cytology in primary cervical screening. |
UK Clinical Research Network |
| 2005 to 2007 |
June '05 to June '07 |
Looking at chemotherapy followed by chemotherapy and radiotherapy together for locally advanced cervical cancer (CxII) |
CancerHelp UK |
| 2005 to 2007 |
Feb '05 and still open |
SCOTCERV A Phase II Study of Docetaxel and Gemcitabine as second line chemotherapy in cervical cancer |
NCRN |
| 2006 to 2007 |
July '06 to July '07 |
Hypoxia imaging with 18F FAZA. Prognostic impact in cervical cancer |
Clinical Trials |
| 2006 to 2007 |
Sept '06 to June '07 |
Cervix cytological screening - comparison of tampon self-test and the routine smear |
Clinical Trials |
| 2006 to 2009 |
|
Sub-study to an international multi-centre, randomised, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 0.5% and 2% PRO 2000/5 gels for the prevention of vaginally acquired HPV infection |
RHRU |
| until 2007 |
until March '07 |
CTCR-CE 01 Dynamic contrast enhanced MRI in combination with tumour molecular profiling as predictors of radiation response in cervix cancer |
NCRN |
| 30th April 2007 |
|
Advaxis announces completion of patient accrual in Lovaxin C phase I/II trial |
PipelineReview.co |
| |
|
The Future II Study Group research "Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions" |
NEJM |
| 2007 to 2008 |
June 2007 to June 2008 |
Assessing the psychosocial burden in women with an abnormal Pap results after screening interventions |
Clinical Trials |